Streetbeat News

Earnings

ANIP

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has raised its FY23 adjusted non-GAAP EPS guidance to $3.62-$4.11 from $2.99-$3.45, beating the consensus of $3.31. The revised guidance represents YoY growth in net revenues of 37%, adjusted non-GAAP EBITDA of 115%, and adjusted non-GAAP earnings per diluted share of 184%.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 10:58 am

ARBE

Arbe Robotics reported Q2 losses of $(0.23) per share, missing the analyst consensus estimate of $(0.15) by 53.33%. The company's quarterly sales were $289.00K, missing the estimate of $460.00K by 37.17%. This represents a 27.78% decrease in EPS and a 76.62% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 10:57 am

ANIP

ANI Pharmaceuticals has increased its FY23 net revenue guidance to $425M-$445M, up from the previous $385M-$410M, surpassing the consensus of $406.41M. The company also raised its FY23 adjusted non-GAAP EBITDA guidance to $115M-$125M from the earlier $97M-$107M.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 10:55 am

BHG

Bright Health Gr (NYSE:BHG) reported Q2 EPS of $(8.55), missing the estimate of $(5.44) by 57.17%. The company also reported quarterly sales of $297.98M, missing the estimate of $752.05M by 60.38%. However, these figures represent an increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 10:55 am

TH

Target Hospitality has provided its 2023 outlook, expecting total revenue between $550M and $580M, adjusted EBITDA between $346M and $365M, and total capital spending between $25M and $35M. The company also aims to achieve zero net debt by the end of 2023. The outlook includes non-cash infrastructure revenue amortization of approximately $117M.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 10:55 am

ODP

ODP Corporation has increased its FY23 adjusted EPS outlook from $4.50 - $5.10 to $5.00 - $5.30, which is higher than the estimated $4.96.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 10:55 am

ODP

ODP Corporation has reduced its revenue forecast for FY23 from a range of $8B - $8.4B to a flat $8B, which is below the estimated $8.2B.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 10:53 am

ANIP

ANI Pharmaceuticals reported Q2 adjusted earnings of $1.28 per share, beating the analyst consensus estimate of $0.68 by 88.24%. This is a 884.62% increase from the same period last year. The company also reported quarterly sales of $116.55 million, beating the analyst consensus estimate of $98.70 million by 18.08%. This is a 57.81% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 10:52 am

ODP

ODP Corporation reported Q2 adjusted earnings of $0.99 per share, beating the analyst consensus estimate of $0.77 by 28.57%. However, the company's quarterly sales of $1.91 billion missed the analyst consensus estimate of $1.98 billion by 3.64%. This represents a 6.19% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 10:51 am

WRBY

Warby Parker has revised its FY23 revenue guidance to $655M-$664M, up from the previous $645M-$660M. This represents a growth of 9.5% to 11.0% compared to FY22. The company also expects an adjusted EBITDA of approximately $52M, or a margin of 7.9%, and plans to open 40 new stores this year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 10:50 am